Bug factories for drugs: quality control holds key to quantityAugust 23, 2004Tiny types of soil bugs already make many of the products we use in washing detergents, foods, and waste treatment, but scientists now hope that similar bacteria will also make the vaccines and drugs of the future, according to new research presented today (Tuesday, 07 September 2004) at the Society for General Microbiology's 155th Meeting at Trinity College Dublin. Researchers from the Institute of Cell and Molecular Studies at Newcastle University have successfully produced small quantities of a promising new vaccine for anthrax using Bacillus bacteria which have been modified to produce human medicines. "Many people already use enzymes produced by these bacteria to wash their clothes," says Professor Colin Harwood of Newcastle University. "But the bacteria which make these enzymes, so useful for digesting dirt, have very efficient quality control systems which spot rogue proteins and enzymes and destroy them. This control mechanism stops us using these bacteria to make large quantities of the pure proteins we need for use in vaccines and other medicines."
The scientists have spent the last ten years, working with a Europe-wide group of 11 research laboratories, discovering how bacteria move enzymes and proteins from inside their cells, where they are made, to the outside world, where they are needed. An important component of the system for moving proteins across the cell membrane turns out to be a quality control mechanism which recognises and breaks down foreign proteins. The bacteria need this checking mechanism to survive in competitive natural environments such as the soil. But this same checking system means that any drug production is disappointingly low if we try to use the bacteria to make useful medicines. "Bacilli could make authentic versions of some of the important proteins we have identified from the results of the Human Genome Project, at concentrations of 20 grammes per litre - which is commercially acceptable," says Prof Harwood. "These bacteria are wonderfully efficient factories, and using them would reduce purification costs and provide structurally authentic proteins." "A better understanding of bacteria will allow us to produce human and animal medicines," says Prof Harwood. "However, since the protein secretion apparatus and quality control systems are also essential for the bacteria's survival, they also give us new targets for antibiotic drugs." Society for General Microbiology | |||||||||||||||||||||
|
Related Bacteria Current Events and Bacteria News Articles NYU scientists discover dangerous new method for bacterial toxin transfer Scientists have discovered a new way for bacteria to transfer toxic genes to unrelated bacterial species, a finding that raises the unsettling possibility that bacterial swapping of toxins and other disease-aiding factors may be more common than previously imagined. Evolution in action: Our antibodies take 'evolutionary leaps' to fight microbes With cold and flu season in full swing, the fact that viruses and bacteria rapidly evolve is apparent with every sneeze, sniffle, and cough. A new report in the January 2009 issue of The FASEB Journal, explains for the first time how humans keep up with microbes by rearranging the genes that make antibodies to foreign invaders. This research fills a significant gap in our understanding of how the immune system helps us survive. Understanding Extinct Microbes May Influence the State of Modern Human Health The study of ancient microbes may not seem consequential, but such pioneering research at the University of Oklahoma has implications for the state of modern human health. Cecil Lewis, assistant professor in the Department of Anthropology, says results of this research raise questions about the microbes living on and within people. Fewer deaths with preventive antibiotic use Administering antibiotics as a preventive measure to patients in intensive care units (ICUs) increases their chances of survival. This has emerged from a study involving nearly sixthousand Dutch patients in thirteen hospitals. Uncultured bacteria found in amniotic fluids of women who experience preterm births Researchers from Case Western Reserve University and Yale University have made a significant advancement in understanding the cause behind why some pregnant women suffer from inflammations in the inner womb without any signs of an infection. Viruses, start your engines! Peering at structures only atoms across, researchers have identified the clockwork that drives a powerful virus nanomotor. Because of the motor's strength--to scale, twice that of an automobile--the new findings could inspire engineers designing sophisticated nanomachines. Research team reports how, when life on Earth became so big In 3.5 billion years, life on earth went from single microscopic cells to giant sequoias and blue whales. Scientists have now documented quantitatively that the increase in maximum size of organisms was not gradual, but happened in two distinct bursts "tied to the geological evolution of the planet," said Michal Kowalewski, professor of geosciences at Virginia Tech. Small molecule triggers bacterial community While bacterial cells tend to be rather solitary individuals, they are also known to form intricately structured communities called biofilms. New research lights up chronic bacterial infection inside bone A new report demonstrates how a sensitive imaging technique gives scientists the upper hand in seeking out bacteria in chronic infections. Peering inside the skull of a mouse to solve meningitis mystery NYU Langone Medical Center scientists and their collaborators at the Scripps Research Institute in La Jolla, Calif., have discovered an unexpected cause for the fatal seizures seen in mice with viral meningitis, an infection of the central nervous system, according to a study published in the journal Nature. More Bacteria Current Events and Bacteria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||